The exclusion of women from clinical trials and other related medical research to the health of millions of women potentially at risk, it was alleged.
Introduced by the University College of London academic Anita Holdcroft, sexual discrimination legislation in the 1970s, has little to the “fundamentally-flawed done” to correct imbalances in medical research.-women health
Recognizing that women have traditionally not been included in clinical,Have trials due to health concerns, makes Professor Holdcroft that “this ban has seen an enormous waste of money and research, a neglect of gender research”.
Who “can women have a other drug efficacy or side effect profile in humans. Only recently it was reported that eight out of ten prescription drugs from the U.S. market because of women’s health issues have been withdrawn,” she says in the editorial of the journal the Royal Society ofMedicine.
Professor Holdcroft goes on to say that “prevent significant barriers”, women of childbearing age from participating in health studies.
“Have [With the rise of medicine as a specialty, a woman, reproductive status, menstrual cycle and contraception and sex] to study health and disease is important. In the UK we should be able to take gender-specific implementation of evidence-based guidelines,” said theycloses.-women health
Commenting on the editorial described Kamran Abbasi, editor of the journal, gender imbalances in medical research as a “miserable”.
“Professor Holdcroft raises fundamental questions not only for researchers and clinicians, but also female patients whose care depends on translating relevant research into practice.”
http://www.womenhealth.pannipa.com/2009/10/research-inequality-harming-womens-health/
“Professor Holdcroft raises fundamental questions not only for researchers and clinicians, but also female patients whose care depends on translating relevant research into practice.”
Tags: ‘Harming, Health’, Inequality, Research, Women’s